美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA218863"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
60219-2279-2 60219-2279 HUMAN PRESCRIPTION DRUG EVEROLIMUS everolimus TABLET, FOR SUSPENSION ORAL 20250114 N/A ANDA ANDA218863 Amneal Pharmaceuticals NY LLC EVEROLIMUS 2 mg/1 4 BLISTER PACK in 1 CARTON (60219-2279-2) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (60219-2279-1)
60219-2280-2 60219-2280 HUMAN PRESCRIPTION DRUG EVEROLIMUS everolimus TABLET, FOR SUSPENSION ORAL 20250114 N/A ANDA ANDA218863 Amneal Pharmaceuticals NY LLC EVEROLIMUS 3 mg/1 4 BLISTER PACK in 1 CARTON (60219-2280-2) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (60219-2280-1)
60219-2281-2 60219-2281 HUMAN PRESCRIPTION DRUG EVEROLIMUS everolimus TABLET, FOR SUSPENSION ORAL 20250114 N/A ANDA ANDA218863 Amneal Pharmaceuticals NY LLC EVEROLIMUS 5 mg/1 4 BLISTER PACK in 1 CARTON (60219-2281-2) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (60219-2281-1)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase